Prostate Cancer Program
David Golombos, MD
Medical Director of Prostate Care Program
Shannen Harbourne, RN, BSN, MS, OCN
Cancer Program Nurse
Elizabeth Schriener, Administrative Assistant II
Free Prostate Cancer Screenings
Prostate cancer is the second leading cause of cancer death in American men, with approximately 31,620 deaths per year. Approximately 1 in 9 men will be diagnosed with prostate cancer and 1 in 41 men will die of prostate cancer. Early detection offers the best chance for long-term survival, which is why the Prostate Specific Antigen (PSA) blood test combined with a brief exam has become a standard in early detection for many men. Stony Brook Medicine's Department of Urology has a long-standing commitment to providing free prostate cancer screenings for at risk individuals. The Prostate Cancer Program team has been recognized for their efforts and has received citations from New York State Senators John Flanagan, Kenneth Lavalle, and New York State Assembly.
We recognize that there is a great deal of debate regarding prostate cancer screening, which is why it is imperative to weigh the risks and benefits of being screened. Participants must meet our guidelines developed from the NCCN (National Comprehensive Care Network) in order to be eligible. Dr. David Golombos, Director of the Stony Brook Prostate Cancer Program states that having knowledge of one’s PSA is “A starting point to an important discussion about prostate cancer”.
The National Comprehensive Cancer Network recommends screenings for men 45-75 years of age who are at average risk, and age 40 for men at high risk of developing prostate cancer. High risk individuals include African Americans males, men who have a first-degree relative (father, brother, or son) diagnosed with prostate cancer at an early age (younger than age 65), and men with a family history of breast, pancreatic, or ovarian cancer.
The Prostate Cancer program offers free screenings throughout the year at various Urology practice locations across Suffolk County, Long Island. In order to streamline the screening process participants are asked to pre-register for the screening event. In addition we ask that you print and complete the pre-screening questionnaire.
|Upcoming FREE Prostate Screenings|
Date: Thursday, January 23, 2020
Please call (631) 444-4000 to register for the event.
Men who are found to have an abnormality (PSA, DRE, or both) are encouraged to follow-up with one of our prostate experts in the Department of Urology to discuss specific options including transrectal ultrasound and prostate biopsy. Patients who are diagnosed with prostate cancer have access to our multidisciplinary team of experts from Urology, Radiation Oncology, Medical Oncology to gain information about appropriate treatments. These options include active surveillance, robotic surgery, radiation therapy, multi-modality therapy, and clinical trials. The multidisciplinary team meets twice monthly in order to discuss the management of prostate cancer and other urologic oncology diseases.
Men who do not have prostate cancer are also encouraged to consult with one of our Urology experts for the management of benign prostate hyperplasia and/or urinary symptoms. Management options offered to patients include observation, medical therapy, and modern surgical techniques (e.g. Greenlight laser therapy, and Urolift).